Neuroimaging
29
5
7
18
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 29 trials
100.0%
+13.4% vs benchmark
3%
1 trials in Phase 3/4
6%
1 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 18 completed trials
Clinical Trials (29)
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
Early Diagnosis of SCD Based on Radiogenomics
Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial
Evaluation of the Implementation of the Hemispheric Dominance During Development
Measurement of Retinal Auto Fluorescence With a Fluorescence Lifetime Imaging Ophthalmoscope
Neural and Physiological Correlates of Psychedelic Sub-states
Fast Brain MRI in Children With Suspected Brain Tumor
iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia
Rural Autistic Individuals - Supporting Expression
Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)
Intervention of Intestinal Microorganism in Mild Cognitive Impairment
Lorazepam Effects on Neuroimaging Measures
The Difference of Grey Matter Volume Among the Patients of Schizophrenia
Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES
Comparing Brain Images Before and After MRI-upgrade - TimFit Upgrade Study
Mindful Self-Regulation fMRI Pilot Study
Vehicle Automation Impact on Drivers
The Study of Acupuncture on Vascular and Functional Neuroimaging in Parkinson's Disease Patients With Sleep Disorders